Skip to content
PICO Portalanswers from OpenAlex

A phase II study investigating the safety and efficacy of neoadjuvant atezolizumab in muscle invasive bladder cancer (ABACUS).

PaperCitations, authors & open-access status

A phase II study investigating the safety and efficacy of neoadjuvant atezolizumab in muscle invasive bladder cancer (ABACUS). is a paper indexed in PICO Portal from OpenAlex.

How many citations does A phase II study investigating the safety and efficacy of neoadjuvant atezolizumab in muscle invasive bladder cancer (ABACUS). have?

PICO Portalcitation count

A phase II study investigating the safety and efficacy of neoadjuvant atezolizumab in muscle invasive bladder cancer (ABACUS). has 90 citations in the OpenAlex counts PICO Portal stores.

When was A phase II study investigating the safety and efficacy of neoadjuvant atezolizumab in muscle invasive bladder cancer (ABACUS). published?

PICO Portalyear

A phase II study investigating the safety and efficacy of neoadjuvant atezolizumab in muscle invasive bladder cancer (ABACUS). has 2018 year in the PICO Portal index.

What is the open-access status of A phase II study investigating the safety and efficacy of neoadjuvant atezolizumab in muscle invasive bladder cancer (ABACUS).?

PICO Portaloa status

A phase II study investigating the safety and efficacy of neoadjuvant atezolizumab in muscle invasive bladder cancer (ABACUS). has closed oa status in the PICO Portal index.

What is the DOI of A phase II study investigating the safety and efficacy of neoadjuvant atezolizumab in muscle invasive bladder cancer (ABACUS).?

PICO Portaldoi

The DOI for A phase II study investigating the safety and efficacy of neoadjuvant atezolizumab in muscle invasive bladder cancer (ABACUS). is on the source record.

What is the OpenAlex record for A phase II study investigating the safety and efficacy of neoadjuvant atezolizumab in muscle invasive bladder cancer (ABACUS).?

PICO Portalopenalex

The OpenAlex for A phase II study investigating the safety and efficacy of neoadjuvant atezolizumab in muscle invasive bladder cancer (ABACUS). is on the source record.

Related on PICO Portal

470M+ articles · 14-day free trial